AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLX 1606 hippurate is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity.
More Information Supplier PageLY 2183240 acts both as a potent inhibitor of the reuptake of the endocannabinoid anandamide, and as an inhibitor of fatty acid amide hydrolase (FAAH), the primary enzyme responsible for degrading anandamide.
More Information Supplier PageLY 2183240 acts both as a potent inhibitor of the reuptake of the endocannabinoid anandamide, and as an inhibitor of fatty acid amide hydrolase (FAAH), the primary enzyme responsible for degrading anandamide.
More Information Supplier PageLY 2183240 acts both as a potent inhibitor of the reuptake of the endocannabinoid anandamide, and as an inhibitor of fatty acid amide hydrolase (FAAH), the primary enzyme responsible for degrading anandamide.
More Information Supplier PageLY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit PI3-K.
More Information Supplier PageLY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit PI3-K.
More Information Supplier PageLY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit PI3-K.
More Information Supplier PageLY344864 is a selective receptor agonist with an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor.
More Information Supplier PageLY344864 is a selective receptor agonist with an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor.
More Information Supplier PageLY344864 is a selective receptor agonist with an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor.
More Information Supplier PageLY 379268 is a highly selective group II mGlu receptor agonist (EC50 values are 2.69 and 4.48 nM for hmGlu2 and hmGlu3 respectively) that displays > 80-fold selectivity over group I and group III receptors.
More Information Supplier PageLY 379268 is a highly selective group II mGlu receptor agonist (EC50 values are 2.69 and 4.48 nM for hmGlu2 and hmGlu3 respectively) that displays > 80-fold selectivity over group I and group III receptors.
More Information Supplier PageLY 379268 is a highly selective group II mGlu receptor agonist (EC50 values are 2.69 and 4.48 nM for hmGlu2 and hmGlu3 respectively) that displays > 80-fold selectivity over group I and group III receptors.
More Information Supplier PageLY 379268 is a highly selective group II mGlu receptor agonist (EC50 values are 2.69 and 4.48 nM for hmGlu2 and hmGlu3 respectively) that displays > 80-fold selectivity over group I and group III receptors.
More Information Supplier PageLY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.
More Information Supplier PageLY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.
More Information Supplier PageLY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis, cell proliferation, cell differentiation, and apoptosis.
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageLY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier Page
